Search hospitals
>
North Dakota
>
Fargo
Sanford Roger Maris Cancer Center
Claim this profile
Fargo, North Dakota 58102
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
320 reported clinical trials
4 medical researchers
Summary
Sanford Roger Maris Cancer Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Sanford Roger Maris Cancer Center is involved with conducting 320 clinical trials across 399 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.
Area of expertise
Lung Cancer
Sanford Roger Maris Cancer Center has run 63 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Sanford Roger Maris Cancer Center has run 49 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Preston D. Steen
Sanford Roger Maris Cancer Center
7 years of reported clinical research
Daniel Almquist
Sanford USD Medical Center - Sioux Falls
3 years of reported clinical research
Samuel Milanovich, MD
Sanford Broadway Medical Center
6 years of reported clinical research
Maria Bell, MD
Sanford Cancer Center Oncology Clinic
9 years of reported clinical research
Clinical Trials running at Sanford Roger Maris Cancer Center
Lung Cancer
Breast Cancer
Breast cancer
Cancer
Ovarian Cancer
Oropharyngeal Carcinoma
Bladder Cancer
Pancreatic Cancer
Laryngeal Cancer
Throat Cancer
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sanford Roger Maris Cancer Center?
Sanford Roger Maris Cancer Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Sanford Roger Maris Cancer Center is involved with conducting 320 clinical trials across 399 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.
Where is Sanford Roger Maris Cancer Center located?
The Sanford Roger Maris Cancer Center is located at 820 Fourth St. N, Fargo, ND 58102.
Who should I call to ask about financial aid or insurance network?
**Sanford Roger Maris Cancer Center Financial Assistance:** - For financial assistance, contact James River Medical Center (JRMC) Cancer Center at (701) 952[...]. They partner with Sanford Health's Roger Maris Cancer Center. **Insurance Inquiries:** - For insurance-related questions, reach out to Sanford Health Plan at (800) 752-5863 or memberservices@sanfordhealth.org. Customer service is available from 8 a.m. to 5 p.m. CST. **Provider Contracting and Fee Negotiation:** - Providers can contact Sanford Health Plan at (855) 263-3544 for contracting or fee schedule negotiation. **Prospective Members:** - Contact Sanford Health Plan's sales team at (888) 535-4831 or sales@sanfordhealth.org for inquiries. **Medicare Advantage Information:** - For Medicare Advantage questions, visit the Medicare Advantage Contact Us page. **Pharmacy Management and Prescription Authorization:** - Contact Sanford Health Plan at (605) 312-2756 or (855) 305-5062 for pharmacy management and prescription drug coverage prior-authorization. **Utilization Management:** - For prior-authorization of medical services and utilization review, contact Sanford Health Plan at (605) 328-6807 or (800) 805-7938. **Care Management Programs:** - For case management, health management, and social work programs, contact Sanford Health Plan at (888) 315-0884. **Agents:** - Agents can reach Sanford Health Plan's sales team at (888) 535-4831 or sales@sanfordhealth.org. **Compliance and Reporting:** - To report potential fraud, waste, and abuse, call the Compliance Hotline at (877)-473-0911 (TTY:711). **NDPERS Health Insurance Partnership:** - For NDPERS partnership inquiries, contact (701) 751-4125 or (800) 499-3416. **Media Relations:** - Contact Sanford Health Media Relations at (605) 366-2432. **24/7 Health Concerns:** - For health concerns, contact My Sanford Nurse at (800) 952-2523, available 24/7.
What insurance does Sanford Roger Maris Cancer Center accept?
The Sanford Roger Maris Cancer Center accepts various insurance plans, including those provided by Sanford Health Plan. For detailed information on accepted insurance plans, please contact the hospital directly or visit their official website.
What awards or recognition has Sanford Roger Maris Cancer Center received?
The Sanford Roger Maris Cancer Center, located in Fargo, North Dakota, is celebrated for its excellence in diversity, equity, and inclusion initiatives by the American Medical Association. It is also recognized as a National Pancreas Foundation Center of Excellence, underscoring its dedication to delivering superior pancreatic cancer care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.